Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities November 22, 2024 Vendor-agnostic, multi-modality Radiology Operations Command Center (ROCC) connects technologists, radiologists, and operations teams in real timeNew FDA 510(k) cleared remote scanning and protocol management help improve the operation of radiology workflows Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major step forward in making radiology expertise for diagnostic imagin...
Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24 Nov. 21, 2024 Industry’s first wide bore, high-performance helium-free [1] 1.5T MR features AI assistance at every step in the MRI workflow, with seamless integration of cloud-based AI image reading and reporting tools on the MR scanner Philips BlueSeal helium-free magnet combined with compact and lightweight design allows flexibility of installations in difficult and remote locations to improve wider access to advanced MRIPhilips’ award-winning [2] AI-based SmartSpeed image...
Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance November 12, 2024 Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to deliver better care for more cancer patients Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration (FDA) for its new detector-based spectral computed tomography (CT) radiotherapy s...
Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)Cardiovascular Institute of the South successfully treats first patient in the U.S. using Philips’ innovative laser system, marking a milestone in advancing personalized care for PAD patients Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a gl...
Les députés ont supprimé vendredi dernier la surtaxe d’Impôt sur les Sociétés proposée par le gouvernement français dans son PLF 2025. Il serait, selon nous, hasardeux de crier victoire trop tôt, et cette disposition pourrait faire son retour durant la suite du débat budgétaire, sous la forme initialement proposée par le gouvernement ou sous une autre. Nous restons prudents sur les actions françaises, le débat budgétaire restant chaotique et pas à la hauteur des enjeux, comme le souli...
Last Friday, MEPs scrapped the exceptional additional corporate tax proposed by the French government in its PLF 2025. In our view, it would be risky to claim victory prematurely, and this provision could make a comeback during the remainder of the budget debate, in the form initially proposed by the government or in another form. We remain cautious on French equities, as the budget debate remains chaotic and fails to live up to the stakes, as underlined by Moody's downgrade of the so...
>China main culprit for weak comp. sales growth, EBITA margin a tad better - Philips reported sales of € 4.44bn or a miss of 1% as css was at € 4.50bn. The comparable sales growth came in at 0.0% whereas consensus was expected +2.1%. The shortfall in comparable sales growth was solely due to China and weak consumer and hospital demand as the Philips CEO indicated saw continued solid growth in the other regions. The comparable order intake declined 2%, which was still...
Rdos. 3T'24 vs 3T'23: Ventas: 4.377 M euros (-2,1% vs +0,9% BS(e) y +0,6% consenso); EBITA Aj.: 516 M euros (+12,9% vs +14,2% BS(e) y +12,9% consenso); BDI: 181 M euros (+101,1% vs +101,1% BS(e) y +92,2% consenso); Rdos. 9meses'24 vs 9meses'23: Ventas: 12.977 M euros (-1,0% vs +0,0% BS(e) y -0,1% consenso); EBITA Aj.: 1.399 M euros (+10,3% vs +10,8% BS(e) y +10,3% consenso); BDI: -365 M euros (-27,1% vs -27,1% BS(e) y -25,5% consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: GRIFOLS. EUROPA: PHILIPS. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. Los mercados descuentan una victoria de Trump Semana marcada por el repunte de las rentabilidades soberanas ante el aumento de probabilidades de una victoria de D. T...
Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world October 28, 2024 Third-quarter highlights Group sales amounted to EUR 4.4 billion, with flat comparable sales growthIncome from operations was EUR 337 millionAdjusted EBITA margin increased by 160 basis points from 10.2% to 11.8% of salesOperating cashflow of EUR 192 million, with a free cashflow of EUR 22 millionComparable order intake decreased by 2%, due to decline in ChinaOutlook for full-year 2024 revised to reflect deteriorated demand in China: c...
Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments October 24, 2024 Both companies also join the newly established World Stroke Organization Advocacy Coalition Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke care is crucial to saving lives and reducing long-term disability. As leaders in stroke diagnosis and treatment, the two organizations...
AkzoNobel: Slight miss on 3Q24, larger miss on year-end leverage Allfunds Group PLC: Strong NNM beat ASM International: Preview 3Q24; probably not too bad Azelis: 3Q24 results preview Heineken: Yet another miss Kinepolis: 3Q24 preview Philips: Preview 3Q24, some upside risk to margins Proximus: 3Q24 preview Events Calendar
Philips showcases next level cardiology innovations for improved patient care at TCT 2024 October 21, 2024 Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for even the most complex procedures.The Philips Engagement Hub in Hall C at the Walter E. Washington Convention Center will feature numerous physician-led discussions, and hands-on trainings that address a range of key challenges in cardiology. ...
With the recall behind us we believe its time to look forward. Ignoring the noise from the recall over the last years, we believe Philips performance was good. Moreover the company’s positioning in IGT, Monitoring, Cardio Ultrasound and MRI has never been better. There is a credible self-help plan to lift Adj EBITA by 70% over the coming 5 years which should position margins and returns at industry average. The discount to the sector is no longer warranted. We upgrade to outperfo...
Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy October 7, 2024 Jakarta, Indonesia and Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Siloam Hospitals Group, Indonesia’s leading private healthcare provider, have signed a Memorandum of Understanding (MoU) to advance AI capabilities and development in the healthcare sector in Indonesia. The strategic collaboration, in partnership with the Universitas Pelita Harapan (UPH) Medical Sciences Group, will focus on c...
Pioneering hospitals take major steps towards decarbonizing healthcare with Philips October 3, 2024 Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower cost Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced significant greenhouse gas (GHG) emissions reduction results following collaboration with customers worldwide to assess and mitigate their carbon footprints, while also enhancing pati...
Jackson Health System projects 47% reduction in carbon emissions from patient monitors with Philips next generation monitoring platform Opportunity for significant savings in energy consumption, reduction of paper and elimination of disposable batteries for telemetry revealed in Life Cycle Assessment Amsterdam, The Netherlands and Cambridge, Mass. and Miami, FL. – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Jackson Health System, one of the nation’s largest public health systems in the United States, today announced results of a collaborative Life Cycle Assessm...
La prochaine acquisition de Campari pourrait être en Inde et intervenir rapidement, selon nous. Rapidement d’abord pour que le groupe puisse pleinement profiter du dynamisme de ce marché. Rapidement ensuite pour se prémunir du ralentissement actuel des liqueurs et apéritifs (L&A) en Europe, segment dont il est historiquement très dépendant. Malgré l’intérêt stratégique du marché indien, une telle opération de M&A pourrait se révéler risquée en s’ajoutant aux multiples défis opérationn...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.